Ochre Bio

About:

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

Website: https://www.ochre-bio.com

Twitter/X: OchreBio

Top Investors: Khosla Ventures, Y Combinator, BACKED VC, Acequia Capital (AceCap), Hoxton Ventures

Description:

Ochre Bio develops genomic medicines to rejuvenate donors' livers before transplant, so that everyone who needs a new liver gets one. They use genomics to find and shut down over-active genes driving disease and then go directly to testing therapies in discarded donor livers that keep alive outside of the body. Ochre Bio is within the heart of Oxford’s biotech innovation hub. Their scientific roots can be traced back to over 15 years leading liver genomics research and experience in bringing advanced therapies to market.